XML 42 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:      
Net income (loss) $ 32,378 $ (200,824) $ (323,492)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 745,499 806,548 866,549
(Gain) loss on real estate assets and joint venture, net (61,536) (55,722) 65,582
Held for sale loss on discontinued operations 20,027 0 0
Impairments 50,548 303,751 305,094
Equity-based compensation 16,751 10,728 14,500
Reserve for loan loss 0 0 15,300
Equity in (income) loss of unconsolidated entities (2,726) 415 (2,361)
Distributions from unconsolidated entities 3,646 1,433 4,873
Gain on early repayment of mortgage notes receivable and sale of investment securities (65) 0 (65)
(Gain) loss on derivative instruments, net (2,976) 1,191 1,460
(Gain) loss on extinguishment and forgiveness of debt, net (18,373) 771 (4,812)
Changes in assets and liabilities:      
Investment in direct financing leases 2,097 3,976 2,035
Rent and tenant receivables and other assets, net (21,394) (52,626) (63,195)
Due from affiliates, net 1,163 (416) 25,489
Assets held for sale classified as discontinued operations 13,812 0 0
Accounts payable and accrued expenses 10,742 (3,323) (999)
Deferred rent, derivative and other liabilities (395) (17,740) (45,934)
Due to affiliates 50 (214) (329)
Liabilities associated with assets held for sale 4,019 0 0
Net cash provided by operating activities 793,267 797,948 859,695
Cash flows from investing activities:      
Investments in real estate assets (699,004) (100,194) (36,319)
Capital expenditures and leasing costs (21,694) (16,568) (18,569)
Real estate developments (14,850) (17,411) (57,682)
Principal repayments received from borrowers 6,796 5,417 6,921
Investments in unconsolidated entities 0 (25,777) 0
Return of investment from unconsolidated entities 1,972 2,580 6,479
Proceeds from disposition of real estate and joint venture 445,525 1,000,700 1,009,107
Investment in leasehold improvements and other assets (1,191) (2,259) (1,911)
Deposits for real estate assets (37,226) (17,856) (16,542)
Proceeds from sale of investments and other assets 400 0 392
Uses and refunds of deposits for real estate assets 36,111 13,305 48,702
Proceeds from the settlement of property-related insurance claims 355 0 839
Line of credit advances to affiliates (16,400) (10,300) (10,000)
Line of credit repayments from affiliates 25,100 50,000 10,000
Net cash (used in) provided by investing activities (274,106) 881,637 941,417
Cash flows from financing activities:      
Proceeds from mortgage notes payable 4,652 3,112 1,445
Payments on mortgage notes payable and other debt, including debt extinguishment and swap termination costs (424,385) (337,022) (188,892)
Proceeds from credit facility 329,000 1,033,000 60,000
Payments on credit facility, including swap termination costs (645,107) (1,993,000) (1,784,000)
Proceeds from corporate bonds 600,000 1,000,000 0
Payments on corporate bonds, including extinguishment costs 0 (1,311,203) 0
Payments of deferred financing costs (9,575) (19,872) (2,436)
Repurchases of common stock under the Share Repurchase Program (518) 0 0
Repurchases of common stock to settle tax obligations (2,148) (4,652) (2,227)
Proceeds from the issuance of Common Stock, net of underwriters’ discount 0 702,765 0
Payments of equity issuance costs 0 (280) 0
Contributions from non-controlling interest holders 101 675 0
Distributions paid (608,615) (580,508) (235,494)
Net cash used in financing activities (756,595) (1,506,985) (2,151,604)
Net change in cash and cash equivalents and restricted cash (237,434) 172,600 (350,492)
Cash and cash equivalents and restricted cash, beginning of period 301,470 128,870 479,362
Less: cash and cash equivalents of discontinued operations (2,973) (4,968) (5,850)
Cash and cash equivalents and restricted cash from continuing operations, beginning of period 298,497 123,902 473,512
Cash and cash equivalents, and restricted cash, end of period 64,036 301,470 128,870
Less: cash and cash equivalents of discontinued operations (2,198) (2,973) (4,968)
Cash and cash equivalents and restricted cash from continuing operations, end of period 61,838 298,497 123,902
Cash and cash equivalents at beginning of period 253,479 64,135 410,861
Restricted cash at beginning of period 45,018 59,767 62,651
Cash and cash equivalents at end of period 34,176 253,479 64,135
Restricted cash at end of period 27,662 45,018 59,767
VEREIT Operating Partnership, L.P. [Member]      
Cash flows from operating activities:      
Net income (loss) 32,378 (200,824) (323,492)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 745,499 806,548 866,549
(Gain) loss on real estate assets and joint venture, net (61,536) (55,722) 65,582
Held for sale loss on discontinued operations 20,027 0 0
Impairments 50,548 303,751 305,094
Equity-based compensation 16,751 10,728 14,500
Reserve for loan loss 0 0 15,300
Equity in (income) loss of unconsolidated entities (2,726) 415 (2,361)
Distributions from unconsolidated entities 3,646 1,433 4,873
Gain on early repayment of mortgage notes receivable and sale of investment securities (65) 0 (65)
(Gain) loss on derivative instruments, net (2,976) 1,191 1,460
(Gain) loss on extinguishment and forgiveness of debt, net (18,373) 771 (4,812)
Changes in assets and liabilities:      
Investment in direct financing leases 2,097 3,976 2,035
Rent and tenant receivables and other assets, net (21,394) (52,626) (63,195)
Due from affiliates, net 1,163 (416) 25,489
Assets held for sale classified as discontinued operations 13,812 0 0
Accounts payable and accrued expenses 10,742 (3,323) (999)
Deferred rent, derivative and other liabilities (395) (17,740) (45,934)
Due to affiliates 50 (214) (329)
Liabilities associated with assets held for sale 4,019 0 0
Net cash provided by operating activities 793,267 797,948 859,695
Cash flows from investing activities:      
Investments in real estate assets (699,004) (100,194) (36,319)
Capital expenditures and leasing costs (21,694) (16,568) (18,569)
Real estate developments (14,850) (17,411) (57,682)
Principal repayments received from borrowers 6,796 5,417 6,921
Investments in unconsolidated entities 0 (25,777) 0
Return of investment from unconsolidated entities 1,972 2,580 6,479
Proceeds from disposition of real estate and joint venture 445,525 1,000,700 1,009,107
Investment in leasehold improvements and other assets (1,191) (2,259) (1,911)
Deposits for real estate assets (37,226) (17,856) (16,542)
Proceeds from sale of investments and other assets 400 0 392
Uses and refunds of deposits for real estate assets 36,111 13,305 48,702
Proceeds from the settlement of property-related insurance claims 355 0 839
Line of credit advances to affiliates (16,400) (10,300) (10,000)
Line of credit repayments from affiliates 25,100 50,000 10,000
Net cash (used in) provided by investing activities (274,106) 881,637 941,417
Cash flows from financing activities:      
Proceeds from mortgage notes payable 4,652 3,112 1,445
Payments on mortgage notes payable and other debt, including debt extinguishment and swap termination costs (424,385) (337,022) (188,892)
Proceeds from credit facility 329,000 1,033,000 60,000
Payments on credit facility, including swap termination costs (645,107) (1,993,000) (1,784,000)
Proceeds from corporate bonds 600,000 1,000,000 0
Payments on corporate bonds, including extinguishment costs 0 (1,311,203) 0
Payments of deferred financing costs (9,575) (19,872) (2,436)
Repurchases of common stock under the Share Repurchase Program (518) 0 0
Repurchases of common stock to settle tax obligations (2,148) (4,652) (2,227)
Proceeds from the issuance of Common Stock, net of underwriters’ discount 0 702,765 0
Payments of equity issuance costs 0 (280) 0
Contributions from non-controlling interest holders 101 675 0
Distributions paid (608,615) (580,508) (235,494)
Net cash used in financing activities (756,595) (1,506,985) (2,151,604)
Net change in cash and cash equivalents and restricted cash (237,434) 172,600 (350,492)
Cash and cash equivalents and restricted cash, beginning of period 301,470 128,870 479,362
Less: cash and cash equivalents of discontinued operations (2,973) (4,968) (5,850)
Cash and cash equivalents and restricted cash from continuing operations, beginning of period 298,497 123,902 473,512
Cash and cash equivalents, and restricted cash, end of period 64,036 301,470 128,870
Less: cash and cash equivalents of discontinued operations (2,198) (2,973) (4,968)
Cash and cash equivalents and restricted cash from continuing operations, end of period 61,838 298,497 123,902
Cash and cash equivalents at beginning of period 253,479 64,135 410,861
Restricted cash at beginning of period 45,018 59,767 62,651
Cash and cash equivalents at end of period 34,176 253,479 64,135
Restricted cash at end of period 27,662 45,018 59,767
2016 Term Loan [Member]      
Cash flows from financing activities:      
Proceeds from 2016 Term Loan 0 300,000 0
Repayment of 2016 Term Loan 0 (300,000) 0
2016 Term Loan [Member] | VEREIT Operating Partnership, L.P. [Member]      
Cash flows from financing activities:      
Proceeds from 2016 Term Loan 0 300,000 0
Repayment of 2016 Term Loan $ 0 $ (300,000) $ 0